NCT06590155View on ClinicalTrials.gov

Erythropoietin in HIE Neonate

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 24, 2024

Primary Completion Date

February 24, 2029

Study Completion Date

February 24, 2029

Conditions
Neonatal Hypoxic Ischemic Encephalopathy
Interventions
DRUG

Erythropoietin

the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy

Trial Locations (1)

71511

Assiut university children hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06590155 - Erythropoietin in HIE Neonate | Biotech Hunter | Biotech Hunter